UK markets open in 2 hours 1 minute
NIKKEI 225
39,080.71 +463.61 (+1.20%) HANG SENG
18,930.02 -265.58 (-1.38%) CRUDE OIL
77.03 -0.54 (-0.70%) GOLD FUTURES
2,374.60 -18.30 (-0.76%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,621.21 -68.15 (-0.12%)
Amphastar Pharmaceuticals, Inc. (29A.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:14AM CEST
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 1.89B |
| Enterprise value | 2.20B |
| Trailing P/E | 14.59 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 3.34 |
| Price/book (mrq) | 3.09 |
| Enterprise value/revenue | 3.53 |
| Enterprise value/EBITDA | 8.86 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.85 |
| 52-week change 3 | -2.74% |
| S&P500 52-week change 3 | 27.84% |
| 52-week high 3 | 59.00 |
| 52-week low 3 | 35.50 |
| 50-day moving average 3 | 38.71 |
| 200-day moving average 3 | 45.91 |
Share statistics
| Avg vol (3-month) 3 | 4 |
| Avg vol (10-day) 3 | N/A |
| Shares outstanding 5 | 48.9M |
| Implied shares outstanding 6 | 51.39M |
| Float 8 | 38.12M |
| % held by insiders 1 | 22.01% |
| % held by institutions 1 | 70.50% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 22.88% |
| Operating margin (ttm) | 27.94% |
Management effectiveness
| Return on assets (ttm) | 11.26% |
| Return on equity (ttm) | 25.34% |
Income statement
| Revenue (ttm) | 676.21M |
| Revenue per share (ttm) | 13.99 |
| Quarterly revenue growth (yoy) | 22.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 256.09M |
| Net income avi to common (ttm) | 154.69M |
| Diluted EPS (ttm) | 2.68 |
| Quarterly earnings growth (yoy) | 65.90% |
Balance sheet
| Total cash (mrq) | 289.56M |
| Total cash per share (mrq) | 5.92 |
| Total debt (mrq) | 627.12M |
| Total debt/equity (mrq) | 93.27% |
| Current ratio (mrq) | 2.17 |
| Book value per share (mrq) | 13.77 |
Cash flow statement
| Operating cash flow (ttm) | 198.41M |
| Levered free cash flow (ttm) | 255.52M |
© 2024 Yahoo. All rights reserved.